Biora Therapeutics (BIOR) Expected to Announce Quarterly Earnings on Tuesday

Biora Therapeutics (NASDAQ:BIOR) is anticipated to post its quarterly earnings results after the market closes on Tuesday, March 25th. Analysts expect Biora Therapeutics to post earnings of ($3.30) per share and revenue of $0.23 million for the quarter.

Biora Therapeutics Price Performance

NASDAQ:BIOR opened at $0.16 on Tuesday. The company has a market cap of $723,680.00, a P/E ratio of -0.01 and a beta of 1.12. The firm’s fifty day moving average price is $0.15 and its two-hundred day moving average price is $2.25. Biora Therapeutics has a one year low of $0.15 and a one year high of $13.30.

Analyst Upgrades and Downgrades

Separately, HC Wainwright upped their price target on shares of Biora Therapeutics from $15.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, November 18th.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.